91 related articles for article (PubMed ID: 24693530)
1. Regional difference in cancer detection rate in prostate cancer screening by a local municipality in Japan.
Koizumi C; Suetomi T; Matsuoka T; Ikeda A; Kimura T; Onozawa M; Miyazaki J; Kawai K; Takahashi H; Akaza H; Nishiyama H
Prostate Int; 2014 Mar; 2(1):19-25. PubMed ID: 24693530
[TBL] [Abstract][Full Text] [Related]
2. Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of <10.0 ng/mL in real-world practice.
Oh KT; Koo KC; Chung BH; Lee KS
Investig Clin Urol; 2020 Jan; 61(1):28-34. PubMed ID: 31942460
[TBL] [Abstract][Full Text] [Related]
3. Population‑based prostate‑specific antigen screening for prostate cancer may have an indirect effect on early detection through opportunistic testing in Kusatsu City, Shiga, Japan.
Kageyama S; Okinaka Y; Nishizawa K; Yoshida T; Ishitoya S; Shichiri Y; Kim CJ; Iwata T; Yokokawa R; Arai Y; Nishikawa Z; Soga H; Ushida H; Sakano Y; Naya Y; Wada A; Nagasawa M; Yoshida T; Narita M; Kawauchi A
Mol Clin Oncol; 2023 Jan; 18(1):3. PubMed ID: 36545210
[TBL] [Abstract][Full Text] [Related]
4. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
[TBL] [Abstract][Full Text] [Related]
5. A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fusion-guided biopsy: assessing the impact of inter-reader variability on cancer detection.
Wajswol E; Winoker JS; Anastos H; Falagario U; Okhawere K; Martini A; Treacy PJ; Voutsinas N; Knauer CJ; Sfakianos JP; Lewis SC; Taouli BA; Rastinehad AR
BJU Int; 2020 Apr; 125(4):531-540. PubMed ID: 31762182
[TBL] [Abstract][Full Text] [Related]
6. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
7. Mass screening of prostate cancer in Changchun City of China.
Li X; Tsuji I; Kuwahara M; Zhang H; Wang H; Zhang L; Ji G; Zhao X
Int Urol Nephrol; 2004; 36(4):541-8. PubMed ID: 15787333
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen screening coverage and prostate cancer incidence rates in the Belgian province of Limburg in 1996-1998.
Lousbergh D; Buntinx F; Geys H; Du Bois M; Dhollander D; Molenberghs G
Eur J Cancer Prev; 2002 Dec; 11(6):547-9. PubMed ID: 12457107
[TBL] [Abstract][Full Text] [Related]
9. Periodic trends in geographical variation of prostate cancer incidence and mortality in Finland between 1985 and 2019.
Seikkula H; Kaipia A; Boström PJ; Malila N; Pitkäniemi J; Seppä K
Acta Oncol; 2022 Oct; 61(10):1209-1215. PubMed ID: 36008888
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.
Schröder FH; Roobol-Bouts M; Vis AN; van der Kwast T; Kranse R
Urology; 2001 Jan; 57(1):83-90. PubMed ID: 11164149
[TBL] [Abstract][Full Text] [Related]
11. Association between family history of prostate cancer and positive biopsies in a Brazilian screening program.
Muller RL; Faria EF; Carvalhal GF; Reis RB; Mauad EC; Carvalho AL; Freedland SJ
World J Urol; 2013 Oct; 31(5):1273-8. PubMed ID: 22820620
[TBL] [Abstract][Full Text] [Related]
12. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
[TBL] [Abstract][Full Text] [Related]
13. Imaging-based prostate cancer screening among BRCA mutation carriers-results from the first round of screening.
Segal N; Ber Y; Benjaminov O; Tamir S; Yakimov M; Kedar I; Rosenbaum E; Sela S; Ozalvo R; Shavit-Grievink L; Keder D; Baniel J; Margel D
Ann Oncol; 2020 Nov; 31(11):1545-1552. PubMed ID: 32958357
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer.
Miller EA; Pinsky PF; Pierre-Victor D
Cancer Causes Control; 2018 Oct; 29(10):907-914. PubMed ID: 30094676
[TBL] [Abstract][Full Text] [Related]
16. Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
Wolters T; Roobol MJ; Bangma CH; Schröder FH
Eur Urol; 2009 Feb; 55(2):385-92. PubMed ID: 18353529
[TBL] [Abstract][Full Text] [Related]
17. Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?
Beckmann K; Kinsella N; Olsson H; Wallerstedt Lantz A; Nordstrom T; Aly M; Adolfsson J; Eklund M; Van Hemelrijck M
BMC Urol; 2019 Aug; 19(1):73. PubMed ID: 31383015
[TBL] [Abstract][Full Text] [Related]
18. [The prostate cancer precision screening program: a preliminary report after recruitment of 2 159 men].
Gu CY; Qin XJ; Huang YQ; Zhu Y; Dai B; Ye DW
Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(42):3292-3297. PubMed ID: 31715663
[No Abstract] [Full Text] [Related]
19. Prostate cancer screening among elderly men in Brazil: should we diagnose or not?
Mori RR; Faria EF; Mauad EC; Rodrigues AA; Dos Reis RB
Int Braz J Urol; 2020; 46(1):34-41. PubMed ID: 31851456
[TBL] [Abstract][Full Text] [Related]
20. Prostate Biopsy Features: A Comparison Between the Pre- and Post-2012 United States Preventive Services Task Force Prostate Cancer Screening Guidelines With Emphasis on African American and Septuagenarian Men.
Shah N; Ioffe V; Cherone S
Rev Urol; 2019; 21(1):1-7. PubMed ID: 31239823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
